News
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...
Similarly, SKF, a Swedish multinational known for industrial and automotive solutions, operates its Global Technical Centre ...
About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
COPENHAGEN, Denmark, April 29, 2025 /PRNewswire/ -- The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting ...
Copenhagen, Denmark: The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting researchers from outside Denmark, in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results